These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 15772895)

  • 1. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of excitatory amino acids in neuropathology].
    Wikinski SI; Acosta GB
    Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
    Yang CR; Svensson KA
    Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?
    Smith PF
    Curr Opin Investig Drugs; 2003 Jul; 4(7):826-32. PubMed ID: 14619404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of memantine.
    Johnson JW; Kotermanski SE
    Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain.
    Long KD; Mastropaolo J; Rosse RB; Manaye KF; Deutsch SI
    Brain Res Bull; 2006 May; 69(6):626-30. PubMed ID: 16716829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of the NMDA-receptor blocker and stimulator ketamine and glycine in the development of a neuropathic pain syndrome].
    Danilova EI; Grafova VN; Reshetniak VK
    Eksp Klin Farmakol; 1997; 60(4):10-3. PubMed ID: 9376747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
    Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
    Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of modulators of N-methyl-D-aspartate receptor-mediated neurotransmission on diazepam discrimination in rats.
    Wiley JL; Balster RL
    Life Sci; 2004 May; 75(2):141-51. PubMed ID: 15120567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease and the glutamate NMDA receptor.
    Doraiswamy PM
    Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate- and GABA-based CNS therapeutics.
    Foster AC; Kemp JA
    Curr Opin Pharmacol; 2006 Feb; 6(1):7-17. PubMed ID: 16377242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of the human NMDA receptor subunit NR3A glycine binding site.
    Nilsson A; Duan J; Mo-Boquist LL; Benedikz E; Sundström E
    Neuropharmacology; 2007 Mar; 52(4):1151-9. PubMed ID: 17320117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate-based therapeutic approaches: inhibitors of glycine transport.
    Lechner SM
    Curr Opin Pharmacol; 2006 Feb; 6(1):75-81. PubMed ID: 16376148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative NMDA receptors in Hydra: a biochemical and functional study.
    Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
    Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
    Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
    Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
    J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.
    Wafford KA; Kathoria M; Bain CJ; Marshall G; Le Bourdellès B; Kemp JA; Whiting PJ
    Mol Pharmacol; 1995 Feb; 47(2):374-80. PubMed ID: 7870047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.